 The biopharmaceutical industry is a high-risk, high-reward industry where stocks soar and plummet with the approval or rejection of drugs. In addition, a strict regulatory framework must govern this sector in order to prevent scams and ineffective or harmful treatments, so most companies have to undertake years of research and extended trials to get a product approved for commercial production. 